2026– date –
-
Bloom X³ News：Congratulations to Dr. Joe Bolen and Orna Therapeutics on the Acquisition by Eli Lilly
Bloom X³ Inc. extends its sincere congratulations to Dr. Joe Bolen, Advisor to Bloom X³ and Chief Executive Officer of Orna Therapeutics, and to the entire Orna team on the announced acquisition by Eli Lilly and Company. According to the... -
Meeting with Nobel Laureate Prof. Shinya Yamanaka
Bloom X³ Inc. (Founder & CEO: Hiromichi Kimura) recently met with Nobel Laureate Prof. Shinya Yamanaka at Gladstone Institutes (a UCSF-affiliated research institute) in California, USA. Prof. Yamanaka is Director Emeritus of the Cent... -
Invited Talk at ASDRP: “Research vs. Business—How to Navigate Career Inflection Points”
Our CEO (Hiro Kimura, Ph.D., R.Ph.) was invited to ASDRP’s Guest Speaker Series and delivered a lecture for high school students in the San Francisco Bay Area.*ASDRP (Aspiring Scholars Directed Research Program): a nonprofit, private res... -
Why Human Judgment Still Matters in AI Drug Discovery: Reproducibility, Credibility, and the Invisible Rules of Scientific Trust
Introduction: AI Is Not a Shortcut to Truth AI is transforming how we discover drugs. It accelerates structural predictions, target discovery, and literature mining. But as its use grows, so does a silent risk: misplaced trust in the cor...
1